Skip to content
Etaracizumab
Etaracizumab is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against integrin beta-3.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
10 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C80313
MelanomaD008545112
Renal cell carcinomaD002292111
Prostatic neoplasmsD011471C6111
Colorectal neoplasmsD015179111
Rheumatoid arthritisD001172EFO_0000685M06.911
PsoriasisD011565EFO_0000676L4011
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LymphomaD008223C85.911
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameETARACIZUMAB
INNetaracizumab
Description
Etaracizumab (humanized mab)
Classification
Antibody
Drug classmonoclonal antibodies
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID892553-42-3
RxCUI
ChEMBL IDCHEMBL1743014
ChEBI ID
PubChem CID
DrugBankDB12213
UNII ID41W9MFI160 (ChemIDplus, GSRS)
Target
Agency Approved
ITGB3
ITGB3
Organism
Homo sapiens
Gene name
ITGB3
Gene synonyms
GP3A
NCBI Gene ID
Protein name
integrin beta-3
Protein synonyms
antigen CD61, CD61, GPIIIa, integrin beta 3, integrin beta chain, beta 3, integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61), Platelet membrane glycoprotein IIIa
Uniprot ID
Mouse ortholog
Itgb3 (16416)
integrin beta-3 (Q3TZC6)
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 174 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details